DK531089D0 - Bicycliske imidazolforbindelser til anvendelse ved behandling af hyperaldosteronisme - Google Patents

Bicycliske imidazolforbindelser til anvendelse ved behandling af hyperaldosteronisme

Info

Publication number
DK531089D0
DK531089D0 DK531089A DK531089A DK531089D0 DK 531089 D0 DK531089 D0 DK 531089D0 DK 531089 A DK531089 A DK 531089A DK 531089 A DK531089 A DK 531089A DK 531089 D0 DK531089 D0 DK 531089D0
Authority
DK
Denmark
Prior art keywords
hyperaldosteronism
treatment
imidazole compounds
compounds
bicyclic imidazole
Prior art date
Application number
DK531089A
Other languages
English (en)
Other versions
DK531089A (da
Inventor
Albert Haeusler
Ajay Bhatnagar
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK531089D0 publication Critical patent/DK531089D0/da
Publication of DK531089A publication Critical patent/DK531089A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK531089A 1988-10-26 1989-10-25 Bicycliske imidazolforbindelser til anvendelse ved behandling af hyperaldosteronisme DK531089A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH399488 1988-10-26

Publications (2)

Publication Number Publication Date
DK531089D0 true DK531089D0 (da) 1989-10-25
DK531089A DK531089A (da) 1990-04-27

Family

ID=4267831

Family Applications (1)

Application Number Title Priority Date Filing Date
DK531089A DK531089A (da) 1988-10-26 1989-10-25 Bicycliske imidazolforbindelser til anvendelse ved behandling af hyperaldosteronisme

Country Status (12)

Country Link
US (1) US5057521A (da)
EP (1) EP0366609B1 (da)
JP (1) JPH02169518A (da)
KR (1) KR900005976A (da)
AT (1) ATE104852T1 (da)
AU (1) AU631814B2 (da)
CA (1) CA2001301A1 (da)
DE (1) DE58907570D1 (da)
DK (1) DK531089A (da)
IE (1) IE63481B1 (da)
IL (1) IL92078A (da)
ZA (1) ZA898074B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH683151A5 (de) * 1991-04-24 1994-01-31 Ciba Geigy Ag Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus.
US6333335B1 (en) 1999-07-23 2001-12-25 Merck & Co., Inc. Phenyl-protein transferase inhibitors
US20030083342A1 (en) * 2002-08-27 2003-05-01 Steele Ronald Edward Combination of organic compounds
ATE327237T1 (de) * 2000-11-17 2006-06-15 Takeda Pharmaceutical Imidazol derivate, ihre herstellung und ihre verwendung
CN1997643A (zh) * 2004-05-28 2007-07-11 斯皮德尔实验股份公司 杂环化合物及其作为醛固酮合酶抑制剂的应用
TW200612947A (en) 2004-05-28 2006-05-01 Speedel Experimenta Ag Organic compounds
US20080076794A1 (en) * 2004-05-28 2008-03-27 Peter Herold Heterocyclic Compounds And Their Use As Aldosterone Synthase Inhibitors
TW200716105A (en) * 2005-05-31 2007-05-01 Speedel Experimenta Ag Imidazole compounds
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
AR056888A1 (es) * 2005-12-09 2007-10-31 Speedel Experimenta Ag Derivados de heterociclil imidazol
EP1842543A1 (en) 2006-04-05 2007-10-10 Speedel Pharma AG Pharmaceutical composition coprising an aldosterone synthase inhibitor and a mineralcorticoid receptor antagonist
DE102008022221A1 (de) * 2008-05-06 2009-11-12 Universität des Saarlandes Inhibitoren der humanen Aldosteronsynthase CYP11B2
US8541404B2 (en) * 2009-11-09 2013-09-24 Elexopharm Gmbh Inhibitors of the human aldosterone synthase CYP11B2
AR086665A1 (es) * 2011-06-14 2014-01-15 Lilly Co Eli Inhibidor de aldosterona sintasa y composiciones farmaceuticas
WO2018078049A1 (en) 2016-10-27 2018-05-03 Damian Pharma Ag Aldosterone synthase inhibitor
CA3097281A1 (en) 2018-05-03 2019-11-07 Damian Pharma Ag R-fadrozole for use in the treatment of aldostonerism
CN110507630A (zh) * 2019-09-29 2019-11-29 陈汝霖 一种便携式腔道杀菌软胶囊

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4889861A (en) * 1982-12-21 1989-12-26 Ciba-Geigy Corp. Substituted imidazo[1,5-a]pyridine derivatives and other substituted bicyclic derivatives and their use as aromatase inhibitors
US4728645A (en) * 1982-12-21 1988-03-01 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridine derivatives and other substituted bicyclic derivatives, useful as aromatase inhibitors
US4617307A (en) * 1984-06-20 1986-10-14 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors
US4588732A (en) * 1982-12-21 1986-05-13 Ciba-Geigy Corporation Certain imidazo(1,5-a)pyridine derivatives and their use as thromboxane synthetase inhibitors

Also Published As

Publication number Publication date
CA2001301A1 (en) 1990-04-26
DE58907570D1 (de) 1994-06-01
AU4372289A (en) 1990-05-31
EP0366609A2 (de) 1990-05-02
ATE104852T1 (de) 1994-05-15
IE893441L (en) 1990-04-26
ZA898074B (en) 1990-08-29
DK531089A (da) 1990-04-27
AU631814B2 (en) 1992-12-10
US5057521A (en) 1991-10-15
IL92078A (en) 1995-08-31
KR900005976A (ko) 1990-05-07
EP0366609B1 (de) 1994-04-27
JPH02169518A (ja) 1990-06-29
EP0366609A3 (de) 1992-01-02
IE63481B1 (en) 1995-05-03
IL92078A0 (en) 1990-07-12

Similar Documents

Publication Publication Date Title
DK531089D0 (da) Bicycliske imidazolforbindelser til anvendelse ved behandling af hyperaldosteronisme
NL930044I2 (nl) ImidazoÄ1,2-aÜ pyridinederivaten, de bereiding hiervan en de therapeutische toepassing.
BG103417A (en) Condensed pyrimidine bicyclic derivatives
DK0802913T3 (da) Imidazo[4,5-c]quinolinaminer
BG101934A (en) Imidazo(1,2-a)pyridine derivatives
ES8308327A1 (es) Un procedimiento para la preparacion de nuevos derivados biciclicos de piridin-5-ona.
NO954878L (no) Pyrrolderivater
DK1109814T3 (da) 5-Heterocyclylpyrazolo[4,3-d]pyrimidin-7-oner til behandling af mandlig erektil dysfunktion
AU549240B2 (en) Imidazo(pyrimido)(1,2-c)quinazoles and imidazol(1,2-c( pyrido)2,3-e)pyrimidines
ID29790A (id) PENGGUNAAN IMIDAZO(1,5-a)-PIRIDO(3,2-e)-PIRAZINON SEBAGAI OBAT
DE69908608D1 (de) Derivate von Imidazo[1,2-a]pyridin zur Behandlung von gastrointestinalen Krankheiten
IT1216772B (it) Derivati di indolo ,procedimento per prepararli e composizioni farmaceutiche che li contengono per il trattamento di emicrania
IL116931A (en) Use of N2-¬¬2-¬4-(2-substituted-benzimidazol-L-YL(and imidazo¬4,5-b¾¬pyridin-1-YL)methyl)phenyl¾-cyclohexyl¾-carbonyl¾glycinamide derivatives in the preparation of pharmaceutical compositions for treatment of restenosis certain such novel compounds and their preparation
EP0370300A3 (de) Cyclopropyl-Substituierte Azolylmethylcarbinole, Verfarhren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DK1025101T3 (da) Naphtho-imidazo[1,2-a]pyridinderivater, deres fremstilling og deres anvendelse ved behandlingen af sygdomme i centralnervesystemet
ES8307811A1 (es) "procedimiento para la preparacion de nuevas imidazo 1,2-a pirimidinas".
DE69400715D1 (de) Verfahren zur Herstellung 4-halo-5(hydroxymethyl)-imidazol Derivate und neue 4-chloro-imidazol Verbindungen
HUP9801596A3 (en) Use of azole compounds for preparing pharmaceutical compositions useful for the treatment of fungal infections, new azole derivatives and pharmaceutical compositions containing them
ES8307810A1 (es) "procedimiento para la preparacion de nuevos 2-metilen-lh-2,3,5,6-tetrahidro-imidazoni,2-a imidazoles".
GB8812620D0 (en) Pharmaceutical composition for treatment of migraine &c
PH24031A (en) Pharmaceutical formulation for the treatment of androgenetic alopecia
SE8604669D0 (sv) Medel for behandling av svampinfektioner i naglar
HRP930588B1 (en) Process for the preparation of therapeutic transdermal system having physostigmine as an active ingredient
NO164544C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive hydrazonderivater med morfinan-skjelett.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment
AHB Application shelved due to non-payment